BSE Live
Apr 20, 15:04Prev. Close
1066.65
Open Price
1069.60
Bid Price (Qty.)
1066.60 (8)
Offer Price (Qty.)
1069.50 (13)
NSE Live
Apr 20, 15:04Prev. Close
1069.65
Open Price
1060.00
Bid Price (Qty.)
1068.00 (3)
Offer Price (Qty.)
1069.10 (3)
| Cash Flow of Alivus Life Sciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 654.13 | 631.29 | 628.61 | 564.93 | 470.94 | |
| Net CashFlow From Operating Activities | 391.52 | 413.52 | 313.40 | 597.59 | 388.11 | |
| Net Cash Used In Investing Activities | -615.65 | -116.48 | -154.15 | -122.23 | -68.73 | |
| Net Cash Used From Financing Activities | -6.23 | -279.44 | -387.59 | -78.80 | -213.78 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -230.35 | 17.59 | -228.33 | 396.56 | 105.60 | |
| Cash And Cash Equivalents Begin of Year | 301.41 | 283.82 | 512.16 | 115.60 | 10.00 | |
| Cash And Cash Equivalents End Of Year | 71.06 | 301.41 | 283.82 | 512.16 | 115.60 |
23.01.2026
Alivus Life Standalone December 2025 Net Sales at Rs 672.89 crore, up 4.84% Y-o-Y
12.11.2025
Alivus Life Standalone September 2025 Net Sales at Rs 587.98 crore, up 16% Y-o-Y
05.08.2025
Alivus Life Standalone June 2025 Net Sales at Rs 601.85 crore, up 2.25% Y-o-Y
25.10.2024
Glenmark Life Standalone September 2024 Net Sales at Rs 506.88 crore, down 14.86% Y-o-Y